Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02234713 · ClinicalTrials.gov registry record · NA
Adherence in Pediatric Multiple Sclerosis
A NA study, sponsored by The Hospital for Sick Children.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT02234713: Completed NA study, sponsored by The Hospital for Sick Children.
NCT02234713 is a NA study that has completed, run by The Hospital for Sick Children. The registered enrollment target is 71 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02234713, a NA study, has completed, sponsored by The Hospital for Sick Children.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
Disease modifying therapies (DMT) are widely used for children and adolescents with MS. Nonetheless, many pediatric patients continue to relapse and therefore require changes in therapy. We designed this research study to learn more about medication use in children and adolescents with MS. We are also interested in learning what a behavioral feedback intervention can tell us about adherence to medicine. Finally, we hope this research project will inform the way we provide clinical care for children and adolescents with MS.
Primary Outcome
Objective measures included: (A) pharmacy refill data provided by site coordinators for 12 months prior to study entry and for 6 months post-study entry and (B) the MEMS cap, an EM device (MEMS, AARDEX) that captures each time the patient discards a needle from their injection or opens their pill bottle. Adherence information from MEMS caps is downloaded and stored on a secured web-platform (medAmigo™). These data were used to compile drug-dosing history data and to calculate medication adherenc
Interventions
- BEHAVIORAL Motivational Interview
- OTHER Video Attention Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2013-01 |
| Est. Completion | 2016-09 |
| Phase | NA |
What the finished NCT02234713 record still lists
NCT02234713 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Motivational Interview is the first listed.
NCT02234713 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02234713 about?
NCT02234713 is a clinical study titled "Adherence in Pediatric Multiple Sclerosis". Disease modifying therapies (DMT) are widely used for children and adolescents with MS. Nonetheless, many pediatric patients continue to relapse and therefore require changes in therapy. We designed this research study to learn more about medication use in children and adolescents with MS. We are al...
What is the current status of trial NCT02234713?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2013-01. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02234713?
The interventions under investigation include: Motivational Interview (BEHAVIORAL), Video Attention Control (OTHER).
Who is sponsoring clinical trial NCT02234713?
This trial is sponsored by The Hospital for Sick Children, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02234713's enrollment target sits among peer trials
71 1102nd of 2000 higher than 898 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia